PexigaNAn MSI-78

General Information


DRACP ID  DRACP00266

Peptide Name   PexigaNAn MSI-78

Sequence  GIGKFLKKAKKFGKAFVKILKK

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Helical peptide with a predominance of one or more amino acids tryptophane-rich

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia 75% Cytotoxicity at 0.5 µg/ml MTT assay 6 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00266

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C122H209N31O23

Absent amino acids  CDEHMNPQRSTWY

Common amino acids  K

Mass  285296

Pl  11.7

Basic residues  9

Acidic residues  0

Hydrophobic residues  10

Net charge  9

Boman Index  -1085

Hydrophobicity  -15.91

Aliphatic Index  93.18

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21403917

Title  Antitumor activity of antimicrobial peptides against U937 histiocytic cell line

Doi Not available

Year  2011

Literature 2

Pubmed ID 8573171

Title  A novel antimicrobial peptide from Bufo bufo gargarizans

Doi 10.1006/bbrc.1996.0071

Year  1996

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.